Home / Insulin Aspart / Germany
DE ATC A10AB05 · updated 2 Nov 2026
Insulin Aspart shortage in Germany
Is there an Insulin Aspart shortage in Germany?
Yes. As of 2 Nov 2026, 2 Insulin Aspart products are reported short in Germany, the first since 31 May 2025. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in Canada, Spain, Austria, Norway, Sweden. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Kirsty 100 Einheiten/ml Injektionslösung im Fertigpen | Biosimilar Collaborations Ireland Limited | 31 May 2025 | 31 Dec 2026 | Manufacturing problem Probleme beim Sonstigen Hersteller |
| DE | Kirsty 100 Einheiten/ml Injektionslösung im Fertigpen | Biosimilar Collaborations Ireland Limited | 31 May 2025 | 31 Dec 2026 | Manufacturing problem Probleme beim Sonstigen Hersteller |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.